James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 28,800 shares at $16.18 ($465K) on 2022-07-15, disclosed to the SEC on 2022-07-15.
Open-market sale of $465k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.13 | 4,544 | $73K | 15.8% |
| 2 | $16.13 | 4,544 | $73K | 15.8% |
| 3 | $16.03 | 2,800 | $45K | 9.7% |
| 4 | $16.18 | 8,456 | $137K | 29.4% |
| 5 | $16.18 | 8,456 | $137K | 29.4% |
| Total | $16.15 avg | 28,800 |
| $465K |
| 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |